Skip to main content
DUKE CAPITAL LIMITED logo

DUKE CAPITAL LIMITED — Investor Relations & Filings

Ticker · DUKE ISIN · GG00BYZSSY63 LEI · 213800GUTKPSJ39SER44 IL Financial and insurance activities
Open in API
Filings indexed 304 across all filing types
Latest filing 2022-03-02 Regulatory Filings
Country GG Guernsey
Listing IL DUKE

About DUKE CAPITAL LIMITED

https://www.dukecapital.com

Duke Capital Limited is a provider of hybrid capital solutions for small and medium-sized enterprises (SMEs). The company's financing model combines features of both debt and equity, offering a unique long-term, evergreen capital solution often described as a 'corporate mortgage'. This approach allows business owners to secure funding for events such as management buyouts, buy-and-build strategies, and shareholder restructuring, while retaining majority control and strategic direction. A key feature of Duke's offering is the elimination of refinancing risk and the pressure for a short-term exit, aligning its returns with the long-term success of its partner companies. The firm's investment pillars focus on capital preservation, attractive dividend yield, and providing upside upon exits.

Recent filings

Filing Released Lang Actions
Follow-On Investment into Existing Royalty Partner
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' and is dated March 2, 2022. It announces a specific corporate action: a follow-on investment into an existing royalty partner (Tristone Healthcare Limited) to fund an acquisition. This type of announcement, which details a specific transaction, financing activity, or material corporate event released via the Regulatory News Service (RNS), fits best under the general 'Regulatory Filings' category, as it is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a specific capital change like a share buyback (POS) or new share issue (SHA). Since it is a formal announcement distributed through RNS, and it doesn't fit the more specific categories like DIV, DIRS, or M&A (TAR), the most appropriate classification is RNS, which serves as the general regulatory announcement fallback.
2022-03-02 English
Follow-On Investment into Existing Royalty Partner
Capital/Financing Update Classification · 99% confidence The document begins with an 'RNS Number' and is dated February 25, 2022. It announces a specific corporate action: a follow-on investment of £1.5 million into an existing royalty partner, Lynx Equity (UK) Ltd., detailing the use of funds (acquisition of Obel-P Automation A/S) and providing highlights and commentary from management. This is a specific, material corporate announcement disseminated via the RNS system. Since it is not a full financial report (10-K, IR), a transcript (CT), or a proxy statement (DEF 14A/PSI), and it details a financing/capital activity, it fits best under Capital/Financing Update (CAP). However, given the context of being a general regulatory news service announcement (RNS) that doesn't fit the highly specific categories like DIV, DIRS, or TAR, and is not a report publication announcement (RPA) but the news itself, the most appropriate general category for material, non-financial-statement news disseminated via RNS is often the fallback, or a specific announcement type. Since it is a financing announcement, CAP is strong, but RNS is the mechanism of delivery. Given the content is a specific announcement about capital deployment, 'CAP' (Capital/Financing Update) is the most descriptive category for the *content*. If the content were purely administrative, RNS would be better. Since it is a material investment announcement, CAP is chosen.
2022-02-25 English
Further re: Directorate Change
Board/Management Information Classification · 99% confidence The document is an official announcement released via RNS (RNS Number : 9135B) on February 17, 2022. The content explicitly discusses a 'Directorate Change,' confirming the appointment of Maree Wilms as a Non-Executive Director and the stepping down of Mark Le Tissier. It includes specific disclosures required by AIM Rule 17 regarding the new director's past and current directorships. This content directly aligns with the definition of 'Board/Management Information' (MANG). Although it is distributed via RNS, the specific subject matter is not general regulatory news but a precise management update.
2022-02-17 English
Follow-On Investment into Existing Royalty Partner
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' RNS filings are general regulatory announcements. The content describes a specific corporate action: a follow-on investment into an existing partner, which is a material event announcement. Since this is a specific announcement distributed via the RNS system and does not fit neatly into categories like 10-K, ER, or DIV, the most appropriate classification is the general regulatory announcement category, RNS. The document length (4842 chars) is substantial enough that it is the announcement itself, not just a pointer to a larger report, but RNS serves as the best fit for this type of market news release.
2022-02-14 English
Directorate Changes
Board/Management Information Classification · 99% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service), indicated by the 'RNS Number' and the footer referencing the London Stock Exchange's RNS service. The core subject of the announcement is 'Directorate Changes,' specifically the appointment of a new Non-Executive Director (Maree Wilms) and the stepping down of another (Mark LeTissier). This content directly matches the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific content is not a general regulatory filing or a report publication announcement, but a specific management change announcement.
2022-02-02 English
Replacement - Trading Update
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number header and the presence of the RNS distribution service footer, indicating it is a regulatory announcement from the London Stock Exchange. The content provides a 'Trading Update' for the third financial quarter ended 31 December 2021 (Q3 FY22), detailing financial highlights (cash revenue) and capital deployments. This type of periodic financial performance summary, which is not the full annual report (10-K) or a comprehensive interim report (IR), but rather an initial release of key results and operational highlights, aligns best with the 'Earnings Release' (ER) definition. Although it contains more detail than a typical press release, its focus on quarterly performance updates makes ER the most appropriate fit among the specific options, rather than the general 'RNS' fallback.
2022-02-01 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.